drugset / Trial / NCT06740422

Xuanhuang Runtong Tablet in the Treatment of Constipation (Yin-deficiency Type)

NCT06740422 ↗

Phase 3 Not yet recruiting 300 enrolled Beijing Hospital of Traditional Chinese Medicine
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This trial is a randomized, double-blind, placebo-controlled parallel-group, multicenter Phase III clinical trial. It is to evaluate the efficacy and safety of Xuanhuang Runtong Tablets in subjects with constipation (Yin-deficiency type) after 4 weeks of treatment.

Timeline

Start
2024-12-15
Primary completion
2026-12-15
Completion
2027-06-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Xuanhuang Runtong Tablet Unknown 7.36 g —

Indications